Hepatitis Market Research Reports & Industry Analysis
Hepatitis Industry Research & Market Reports
-
North America Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029
... North America Oral Antiviral Market would witness market growth of 1.7% CAGR during the forecast period (2023-2029). There is a market opportunity for oral antiviral products due to expansion and innovation in the pharmaceutical sector. ... Read More
-
Point-of-Care Diagnostics Market by Platform (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood Glucose Monitoring, Hematology, Tumor), Sample Type (Blood, Urine), and End User—Global Forecast to 2030
... (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood Glucose Monitoring, Hematology, Tumor), Sample Type (Blood, Urine), and End User—Global Forecast to 2030 The global point-of-care diagnostics market is projected to reach $43.1 ... Read More
-
2023 Global: Hepatitis Test Solution/Diagnosis Market - Innovative Markets Forecast (2029) report
... the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 ... Read More
-
Hepatitis Diagnostic Tests Market - By Product (Instruments, Reagents & Kits), By Technology (Enzyme-Linked Immunosorbent Assay, Rapid diagnostic tests, Polymerase Chain Reaction), By Test Type (Blood Test, Imaging Test), By End-use & Forecast, 2023 - 2032
... 2032 Global Hepatitis Diagnostic Tests Market will gain significant momentum over 2023-2032, owing to the high incidence rate of hepatitis infections, especially hepatitis B and C, worldwide fueling the demand for effective diagnostic tests. The ... Read More
-
Global Liver Disease Treatment Market Size study & Forecast, by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, Others) and Regional Analysis, 2022-2029
... Others) and Regional Analysis, 2022-2029 Global Liver Disease Treatment Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the ... Read More
-
Point of Care Molecular Diagnostics Market: By Product and Service (Assays & Kits, Instruments & Analyzers, Software & Services), By Technology (RT-PCR, INAAT, Other Technologies), By Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospital-acquired Infections, Cancer, Hepatitis, Gastrointestinal Disorders, Other Applications), By End-User (Physicians’ Offices, Hospitals & ICUs, Research Institutes, Other End Users) And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031
... Hepatitis, Gastrointestinal Disorders, Other Applications), By End-User (Physicians’ Offices, Hospitals & ICUs, Research Institutes, Other End Users) And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031 Point ... Read More
-
Hepatitis C Virus Infection- Pipeline Insight, 2023
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
2023 Global Forecast for Hepatitis Test Solution/Diagnosis Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
Hepatitis Diagnostic Test Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... in its initial phase was adverse owing to cancellations of diagnostic procedures worldwide. For instance, a research article published in the Journal of Hepatology in July 2022 stated that the COVID-19 pandemic hampered HBV and ... Read More
-
Molecular Diagnostics Market - By Product (Instruments, Reagents & Kits), By Technology (Polymerase Chain Reaction, Hybridization, Sequencing, Microarrays), By Application (Infectious Disease Diagnostics {COVID-19, HIV, CT/NG, Hepatitis B, Hepatitis C, RSV, Flu, Tuberculosis}, Genetic Disease Testing), By End-use (Diagnostics Laboratories, Hospitals & Clinics) & Forecast, 2023 - 2032
... Testing), By End-use (Diagnostics Laboratories, Hospitals & Clinics) & Forecast, 2023 - 2032 Molecular diagnostics market is poised to witness lucrative gains through 2032, owing to the surging geriatric population. As per WHO, 1 in ... Read More
-
Global Hepatitis C Detection Kit Market Growth 2023-2029
... at a CAGR of % from 2023 to 2029. United States market for Hepatitis C Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of ... Read More
-
Pediatric Vaccines Market, By Vaccine Type (Pneumococcal Vaccine, DTP Vaccine, Rotavirus Vaccine, MMR Vaccine, Polio Vaccine, Influenza Vaccine, Hepatitis B Vaccine, Meningococcal Vaccine, Hib Vaccine, Varicella Vaccine), By Technology (Live or Attenuated Vaccine, Inactivated or Killed Vaccine, Toxoid Vaccine, Conjugate Vaccine, Subunit Vaccine, Recombinant Vaccine), By Type (Monovalent Vaccine and Multivalent Vaccine), By Distribution Channel (Government and Private), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Killed Vaccine, Toxoid Vaccine, Conjugate Vaccine, Subunit Vaccine, Recombinant Vaccine), By Type (Monovalent Vaccine and Multivalent Vaccine), By Distribution Channel (Government and Private), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, ... Read More
-
PEGylated Proteins Market by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia,
... User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2023-2028 Market Overview: The global PEGylated proteins market size reached US$ 1.16 Billion in 2022. Looking forward, IMARC Group expects the ... Read More
-
Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User & Region - Global Forecast to 2028
... nucleic acid amplification technology market is projected to reach USD 6.8 Billion by 2028 from USD 4.4 Billion in 2023, at a CAGR of 9.2% during the forecast period. Increasing prevalence of infectious diseases, launches ... Read More
-
Hepatitis C Drug Market
... grew from USD 6.73 billion in 2022 tUSD 8.87 billion by 3032, exhibiting a CAGR of 2.5% during the forecast period. In addition, the study includes supply and demand risk, market attractiveness, BPS analysis, and ... Read More
-
Global PEGylated Proteins Market Size study & Forecast, by Protein Type (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, Others), by Product & Services (Consumables, Services), by Application (Cancer, Autoimmune diseases, Hepatitis, Multiple sclerosis, Hemophilia, Gastrointestinal disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029
... disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029 Global PEGylated Proteins Market is valued at approximately USD 1.14 billion in 2021 and is anticipated ... Read More
-
Virus-Like Particles (VLP’s) Market Analysis And Forecast To 2032: By Product Type (Hepatitis, Cancer/HPV, Gaucher Disease), Source (Yeast, Insect Cell, Plant, Others), Application (Vaccine, Therapeutics), And Region
... period. Virus-like particles (VLPs) are multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccine candidates. Market Trends and Drivers Consistent R&D ... Read More
-
Middle East & Africa Immunodiagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)
... Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others) The MEA immunodiagnostics market is expected to grow from US$ 591.94 million in 2022 to US$ 927.14 million ... Read More
-
Asia-Pacific Immunodiagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)
... Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others) The APAC immunodiagnostics market is expected to grow from US$ 2,231.31 million in 2022 to US$ 3,587.50 million by 2028; it ... Read More
-
Europe Immunodiagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)
... Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others) The Europe immunodiagnostics market is expected to grow from US$ 5,734.92 million in 2022 to US$ 8,686.76 million by 2028; it ... Read More
-
Preventive Vaccines Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... increasing in recent years during the pandemic, and their use is also increasing in many parts of the world. Major firms' practices, such as continual research and development for bringing new technologies to save costs ... Read More
-
South America Immunodiagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)
... Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others) The South America immunodiagnostics market is expected to grow from US$ 887.91 million in 2022 to US$ 1,399.57 million by 2028; ... Read More
-
Hepatitis Diagnostic Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 7.5 Billion by 2028, exhibiting a growth rate (CAGR) of 5.1% during 2023-2028. Hepatitis represents a major global health threat that requires an urgent response. According to estimates, hepatitis causes 1.3 Million-1.5 Million ... Read More
-
Point of Care Molecular Diagnostics Market Size by Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhoea, Chlamydia, Hepatitis C, Hepatitis B, COVID-19}, Oncology, Hematology), By End-use (Hospitals, Clinics, Diagnostic Centers), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Oncology, Hematology), By End-use (Hospitals, Clinics, Diagnostic Centers), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 Point of Care Molecular Diagnostics Market is anticipated to register growth through ... Read More
-
Lateral Flow Assays Market Size By Product (Kits, Readers), By Application (Infectious Disease Testing {Influenza, STDs, Hepatitis, Tuberculosis}, Cardiac Metabolic Testing {CK-MB Testing, Myoglobin, D-dimer, Troponin I}, Pregnancy & Fertility Testing {Pregnancy Testing, Fertility Testing}, Cholesterol Testing, Drug of Abuse), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-use (Hospital & Clinics, Diagnostic Laboratories, Homecare Settings), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Cholesterol Testing, Drug of Abuse), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-use (Hospital & Clinics, Diagnostic Laboratories, Homecare Settings), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market ... Read More
Research Assistance
